An American traveler’s observations about everyday Italian home quirks have gone viral on TikTok.

Graham Platner’s anti-establishment run for US Senate in Maine was supposed to validate Democrats’ desire for younger ...

In today’s homes, the bathroom has evolved beyond function. It became a renewed space for comfort, design, and technology. It can feel overwhelming to start, and even more so to invest, in smart ...

A portable espresso maker for those who absolutely don't want to leave behind their favorite $500 espresso maker. It's ...

We independently review everything we recommend. When you buy through our links, we may earn a commission. Learn more› By Doug Mahoney Doug Mahoney is a writer covering home-improvement topics, ...

On a recent episode of his podcast with fellow wellness coach Sam Leicht, Williamson learned about a hygienic tool that could help him set a PR when it comes to cleanliness. The concept of a bidet is ...

The drug combo could slash the risk of tumour growth, delay worsening of symptoms and even improve life expectancy MEN with aggressive prostate cancer could benefit from a new drug combination that ...

Lurbinectedin, combined with atezolizumab or atezolizumab and hyaluronidase, is FDA-approved for ES-SCLC patients without disease progression post-induction therapy. Lurbinectedin is administered ...

What used to be America's most budget-friendly dining option has become expensive across top metropolitan areas. Cities like Seattle, NYC, and LA now see fast food rivaling traditional restaurant ...

FDA approved Tecentriq and lurbinectedin combination for ES-SCLC maintenance therapy, reducing disease progression and mortality risks significantly. The Phase III IMforte study showed a 46% reduction ...

Please provide your email address to receive an email when new articles are posted on . The FDA approved the combination of lurbinectedin and atezolizumab as first-line maintenance treatment for ...